Development and validation of a novel defined mutation classifier based on Lasso logistic regression for predicting the overall survival of immune checkpoint inhibitor therapy in renal cell carcinoma

BACKGROUND: Currently, immune checkpoint inhibitor (ICI)-based therapy has become the first-line treatment for advanced renal cell carcinoma (RCC). However, few biomarkers have been identified to predict the response to ICI therapy in RCC patients. Herein, our research aimed to build a gene mutation...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Minyu, Li, Pengju, Yao, Haohua, Liu, Fei, Fu, Liangmin, Wang, Yinghan, Zhu, Jiangquan, Xu, Quanhui, Liang, Hui, Zhou, Yayun, Wang, Zhu, Deng, Qiong, Chen, Wei, Cao, Jiazheng, Chen, Xu, Luo, Junhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080346/
https://www.ncbi.nlm.nih.gov/pubmed/37032757
http://dx.doi.org/10.21037/tau-23-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080346/
https://www.ncbi.nlm.nih.gov/pubmed/37032757
http://dx.doi.org/10.21037/tau-23-21

Ejemplares similares